Clinical Trial Update: Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intranasal fluticasone propionate, delivered via a novel bi-directional device, for bilateral nasal polyposis; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bilateral Nasal Polyposis

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)

Snippet

Sponsor: Optinose US Inc. | Conditions: Bilateral Nasal Polyposis | Phase 3 | Status: COMPLETED | Results posted: 2018-12-05